A growing body of evidence has suggested EBV is a major environmental risk factor for MS. Learn more about its association with the disease.| Multiple Sclerosis News Today
MRI is an imaging technique that can aid in diagnosing MS. Learn more about how this tool is used to detect MS and assess damage in the CNS.| Multiple Sclerosis News Today
Abata Therapeutics has chosen its first treatment candidate for development: the T-cell therapy ABA-101 for certain forms of progressive MS.| Multiple Sclerosis News Today
Symptoms and early signs of MS vary from person to person. Common symptoms include movement problems, pain, fatigue, and vision problems.| Multiple Sclerosis News Today
MS is not usually fatal, but it may increase the risk of life-threatening complications. Learn more about MS progression and life expectancy.| Multiple Sclerosis News Today
MS is defined by the presence of lesions in the nervous system. Learn more about MS lesions and view a picture of what brain lesions look like on an MRI.| Multiple Sclerosis News Today
Cognitive rehabilitation, with or without aerobic exercise, led to increased tissue volume and activity in brain regions linked to cognition.| Multiple Sclerosis News Today
MS is an autoimmune disease that affects the central nervous system. Learn more about MS types, causes, symptoms, diagnosis, and treatment.| Multiple Sclerosis News Today